Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients
Chimeric antigen receptor (CAR) T cells are considered genetically modified organisms (GMOs) and constitute gene therapy medicinal products. Thus, CAR T cell manufacturing for clinical application is strictly regulated. Appropriate methods to assess vector copy numbers (VCNs) in CAR T cell products...
Main Authors: | Alexander Kunz, Ulrike Gern, Anita Schmitt, Brigitte Neuber, Lei Wang, Angela Hückelhoven-Krauss, Birgit Michels, Susanne Hofmann, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Maria-Luisa Schubert |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050120300280 |
Similar Items
-
Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR
by: Maria-Luisa Schubert, et al.
Published: (2020-09-01) -
Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
by: Susanne Hofmann, et al.
Published: (2019-02-01) -
Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum
by: Megan R. Ansbro, et al.
Published: (2020-05-01) -
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy
by: Mingya Yang, et al.
Published: (2021-05-01) -
Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products
by: Alex Lu, et al.
Published: (2020-05-01)